Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Pegylated Interferon Plus Ribavirin Combination Therapy in Treating Older Patients With Chronic Hepatitis C
Conditions
Interventions
pegylated interferon alpha and plus ribavirin
pegylated interferon alpha and plus ribavirin
+1 more
Locations
1
Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Start Date
February 1, 2007
Primary Completion Date
April 1, 2009
Completion Date
April 1, 2009
Last Updated
September 8, 2010
NCT00199719
NCT06922643
NCT03612973
NCT01866930
NCT05895448
NCT02219490
Lead Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions